NCT00191347View on ClinicalTrials.gov

A Study of Biweekly Pemetrexed and Gemcitabine in Patients With Metastatic Breast Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

October 31, 2004

Study Completion Date

November 30, 2005

Conditions
Breast Cancer
Interventions
DRUG

pemetrexed

DRUG

gemcitabine

Trial Locations (1)

Unknown

For additional information regarding investigative sites for thsi trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Ottawa

All Listed Sponsors
lead

Eli Lilly and Company

INDUSTRY

NCT00191347 - A Study of Biweekly Pemetrexed and Gemcitabine in Patients With Metastatic Breast Cancer | Biotech Hunter | Biotech Hunter